Xanthan lyase

BE0003288ProteinBacillus sp. (strain GL1)xly

Plays a role in xanthan depolymerization pathway by cleaving the linkage between the terminal mannosyl and glucuronyl residues of the side chain of xanthan to liberate pyruvylated mannose. It is acted on by 4 drugs in DrugBank.

Gene name
xly
UniProtKB entry
Q9AQS0Swiss-Prot
Cellular location
Secreted
Residues / weight
930 residues · 99,312 Da
Also known as
4.2.2.12

Resolves to

Protein
UniProtQ9AQS0UniProt nameXANLY_BACGL
Structure
PDB1J0MPDB1J0NPDB1X1H
Drugs

What you can answer from here — as of September 07, 2019

4DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
5GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Xanthan lyase, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In